Value of Drug-Eluting Stents in Cardiac Transplant Recipients

American Journal of Cardiology

Volumn 103, Issue 5, 2009, Pages 659-662

  Gupta, Anuj ^a   Mancini, Donna ^a   Kirtane, Ajay J ^a   Kaple, Ryan K ^a   Apfelbaum, Mark A ^a   Kodali, Susheel K ^a   Marboe, Charles ^a   Leon, Martin B ^a   Moses, Jeffrey W ^a   Rabbani, LeRoy E ^a  

^a NewYork Presbyterian Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; RAPAMYCIN; TICLOPIDINE;

ADULT; AGED; ARTICLE; BARE METAL STENT; CARDIAC ALLOGRAFT VASCULOPATHY; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY STENT; DRUG ELUTING STENT; FEMALE; HEART TRANSPLANTATION; HUMAN; KAPLAN MEIER METHOD; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; STENT THROMBOSIS; SURVIVAL;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY DISEASE; CORONARY RESTENOSIS; DRUG-ELUTING STENTS; FEMALE; HEART TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; SIROLIMUS; SURVIVAL RATE;

EID: 60249099149     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2008.10.042     Document Type: Article

References (11)

1. Taylor D.O., Edwards L.B., Boucek M.M., Trulock E.P., Waltz D.A., Keck B.M., and Hertz M.I. Registry of the International Society for Heart and Lung Transplantation: twenty-third official adult heart transplantation report-2006. J Heart Lung Transplant 25 (2006) 869-879
2. McKay M., Pinney S., Gorwara S., Burke E.M., Sciacca R.R., Apfelbaum M., Mancini D., Itescu S., and Rabbani L.E. Anti-human leukocyte antigen antibodies are associated with restenosis after percutaneous coronary intervention for cardiac allograft vasculopathy. Transplantation 79 (2005) 1581-1587
3. Jonas M., Fang J.C., Wang J.C., Giri S., Elian D., Har-Zahav Y., Ly H., Seifert P.A., Popma J.J., and Rogers C. In-stent restenosis and remote coronary lesion progression are coupled in cardiac transplant vasculopathy but not in native coronary artery disease. J Am Coll Cardiol 48 (2006) 453-461
4. Bader F.M., Kfoury A.G., Gilbert E.M., Barry W.H., Humayun N., Hagan M.E., Thomas H., and Renlund D. Percutaneous coronary interventions with stents in cardiac transplant recipients. J Heart Lung Transplant 25 (2006) 298-301
5. Tanaka K., Li H., Curran P.J., Takano Y., Arbit B., Currier J.W., Yeatman L.A., Kobashigawa J.A., and Tobis J.M. Usefulness and safety of percutaneous coronary interventions for cardiac transplant vasculopathy. Am J Cardiol 97 (2006) 1192-1197
6. Halle A.A., Disciascio G., Massin E.K., Wilson R.F., Johnson M.R., Sullivan H.J., Bourge R.C., Kleiman N.S., Miller L.W., Aversano T.R., et al. Coronary angioplasty, atherectomy and bypass surgery in cardiac transplant recipients. J Am Coll Cardiol 26 (1995) 120-128
7. Keogh A., Richardson M., Ruygrok P., Spratt P., Galbraith A., O'Driscoll G., Macdonald P., Esmore D., Muller D., and Faddy S. Sirolimus in de novo heart transplant recipients reduces acute rejection and prevents coronary artery disease at 2 years: a randomized clinical trial. Circulation 110 (2004) 2694-2700
8. Eisen H.J., Tuzcu E.M., Dorent R., Kobashigawa J., Mancini D., Valantine-von Kaeppler H.A., Starling R.C., Sørensen K., Hummel M., Lind J.M., Abeywickrama K.H., Bernhardt P., and RAD B253 Study Group. Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients. N Engl J Med 349 (2003) 847-858
9. Hirohata A., Nakamura M., Waseda K., Honda Y., Lee D.P., Vagelos R.H., Hunt S.A., Valantine H.A., Yock P.G., Fitzgerald P.J., Yeung A.C., and Fearon W.F. Changes in coronary anatomy and physiology after heart transplantation. Am J Cardiol 99 (2007) 1603-1607
10. Gregory S.A., Ferencik M., Achenbach S., Yeh R.W., Hoffmann U., Inglessis I., Cury R.C., Nieman K., McNulty I.A., Laffan J.A., et al. Comparison of sixty-four-slice multidetector computed tomographic coronary angiography to coronary angiography with intravascular ultrasound for the detection of transplant vasculopathy. Am J Cardiol 98 (2006) 877-884
11. Mehra M.R., Uber P.A., Potluri S., Ventura H.O., Scott R.L., and Park M.H. Usefulness of an elevated B-type natriuretic peptide to predict allograft failure, cardiac allograft vasculopathy, and survival after heart transplantation. Am J Cardiol 94 (2004) 454-458